Y-mAbs Therapeutics, Inc. (YMAB)

NASDAQ: YMAB · Real-Time Price · USD

8.51

0.00 (0.00%)

At close: Aug 13, 2025, 4:00 PM

8.52

+0.01 (0.12%)

Pre-market: Aug 14, 2025, 8:56 AM EDT

Y-mAbs Therapeutics Market Cap

Y-mAbs Therapeutics has a market cap or net worth of $386.68 million as of August 14, 2025. Its market cap has decreased by -29.68% in one year.

Market Cap

386.68M

Enterprise Value

327.51M

1-Year Change

-29.68%

Ranking

#3195

Market Cap Chart

Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $386.68M, a decrease of -51.47%. That is a compound annual growth rate of -9.95%.

Market Cap History

Date	Market Cap	% Change
Aug 12, 2025	386.68M	10.26%
Dec 31, 2024	350.70M	17.88%
Dec 29, 2023	297.50M	39.61%
Dec 30, 2022	213.10M	-69.88%
Dec 31, 2021	707.47M	-64.73%
Dec 31, 2020	2.01B	61.56%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	561.67B
Johnson & Johnson	417.44B
AbbVie	349.87B
Abbott Laboratories	233.71B
AstraZeneca	227.85B
UnitedHealth Group	227.59B
Novartis AG	225.61B
Novo Nordisk	224.34B

Market Cap Rankings